Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Exploring Apolipoprotein E4 as a Genetic Marker for Postoperative C5 Plasy: A prospective case-control study

FY 2023-24

Summary
The leading cause of spinal cord injury among adults is degenerative cervical myelopathy (DCM). This condition arises from age-related changes that compress the spinal cord leading to symptoms such as hand numbness, difficulty walking, and in severe cases, muscle weakness in all four limbs. Typically, patients are recommended to undergo spinal surgery as a treatment for DCM. While this surgical procedure aims to alleviate these symptoms, it also can cause a complication called C5 palsy, a condition causing persistent weakness in the shoulder and arm muscles. Research indicates that a specific gene, apolipoprotein E ?4 (APOE4), negatively influences the recovery from neurodegenerative conditions such as DCM. Despite this, to our knowledge, no research has explored whether APOE4 increases the likelihood of developing C5 palsy after surgery for DCM. To investigate this, we will recruit 50 participants who have undergone surgery to treat their DCM. Among these participants, half will have post-surgery C5 palsy, and half will not. Blood samples will be collected from all participants to determine if they are carriers of APOE4. We will compare these two groups to idenitfy the potential link between the incidence of C5 palsy and the presence of APOE4. We hypothesize that patients who are carriers of APOE4 are more likely to develop C5 palsy after surgery. If we are correct, healthcare professionals could recommend APOE4 testing to assess their patients susceptibility to post-surgery C5 palsy. This knowledge could empower patients in making more informed decisions regarding their treatment, leading to increased patient satisfaction. Moreover, our findings could serve as a foundation for future studies exploring gene therapies aimed at preventing or treating C5 palsy.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506553
Name
Wilson Vanessa V
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring Apolipoprotein E4 as a Genetic Marker for Postoperative C5 Plasy: A prospective case-control study
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apoe4; Apolipoprotein E4; C5 Nerve Root Palsy; C5 Palsy; Cervical Spondylotic Myelopathy; Degenerative Cervical Myelopathy; Spinal Cord Injury
Abstract
The leading cause of spinal cord injury among adults is degenerative cervical myelopathy (DCM). This condition arises from age-related changes that compress the spinal cord leading to symptoms such as hand numbness, difficulty walking, and in severe cases, muscle weakness in all four limbs. Typically, patients are recommended to undergo spinal surgery as a treatment for DCM. While this surgical procedure aims to alleviate these symptoms, it also can cause a complication called C5 palsy, a condition causing persistent weakness in the shoulder and arm muscles. Research indicates that a specific gene, apolipoprotein E ?4 (APOE4), negatively influences the recovery from neurodegenerative conditions such as DCM. Despite this, to our knowledge, no research has explored whether APOE4 increases the likelihood of developing C5 palsy after surgery for DCM. To investigate this, we will recruit 50 participants who have undergone surgery to treat their DCM. Among these participants, half will have post-surgery C5 palsy, and half will not. Blood samples will be collected from all participants to determine if they are carriers of APOE4. We will compare these two groups to idenitfy the potential link between the incidence of C5 palsy and the presence of APOE4. We hypothesize that patients who are carriers of APOE4 are more likely to develop C5 palsy after surgery. If we are correct, healthcare professionals could recommend APOE4 testing to assess their patients susceptibility to post-surgery C5 palsy. This knowledge could empower patients in making more informed decisions regarding their treatment, leading to increased patient satisfaction. Moreover, our findings could serve as a foundation for future studies exploring gene therapies aimed at preventing or treating C5 palsy.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wilson, Vanessa V
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~